These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1448798)
1. Low dose infusion of adenosine diphosphate prolongs bleeding time in rats and rabbits. Aursnes I; Stenberg-Nilsen H Thromb Res; 1992 Oct; 68(1):67-74. PubMed ID: 1448798 [TBL] [Abstract][Full Text] [Related]
2. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting. Michel G; Seipp U Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087 [TBL] [Abstract][Full Text] [Related]
3. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline. Michal F; Motamed M Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo. Humphries RG; Tomlinson W; Clegg JA; Ingall AH; Kindon ND; Leff P Br J Pharmacol; 1995 Jul; 115(6):1110-6. PubMed ID: 7582510 [TBL] [Abstract][Full Text] [Related]
6. Treatment with fibrinogen γ-chain peptide-coated, adenosine 5'-diphosphate-encapsulated liposomes as an infusible hemostatic agent against active liver bleeding in rabbits with acute thrombocytopenia. Hagisawa K; Nishikawa K; Yanagawa R; Kinoshita M; Doi M; Suzuki H; Iwaya K; Saitoh D; Seki S; Takeoka S; Handa M; Nishida Y Transfusion; 2015 Feb; 55(2):314-25. PubMed ID: 25145766 [TBL] [Abstract][Full Text] [Related]
7. Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels. Data JL; Molony BA; Meinzinger MM; Gorman RR Circulation; 1981 Jul; 64(1):4-12. PubMed ID: 6263515 [TBL] [Abstract][Full Text] [Related]
8. Adrenaline Improves Platelet Reactivity in Ticagrelor-Treated Healthy Volunteers. Singh S; Damén T; Nygren A; Shams Hakimi C; Ramström S; Dellborg M; Lindahl TL; Hesse C; Jeppsson A Thromb Haemost; 2019 May; 119(5):735-743. PubMed ID: 30780166 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet and antithrombotic activities of salvianolic acid A. Fan HY; Fu FH; Yang MY; Xu H; Zhang AH; Liu K Thromb Res; 2010 Jul; 126(1):e17-22. PubMed ID: 20451955 [TBL] [Abstract][Full Text] [Related]
10. Correction effect of ATP on platelet aggregation and blood coagulation in vitro and in the presence of circulating thrombin in rats. Pastorova VE; Lyapina LA Bull Exp Biol Med; 2007 Apr; 143(4):389-91. PubMed ID: 18214281 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes as a haemostatic adjuvant for post-cardiopulmonary bypass coagulopathy. Ishida O; Hagisawa K; Yamanaka N; Tsutsumi K; Suzuki H; Takikawa M; Takeoka S; Kinoshita M Sci Rep; 2020 Jul; 10(1):11308. PubMed ID: 32647296 [TBL] [Abstract][Full Text] [Related]
12. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849 [TBL] [Abstract][Full Text] [Related]
14. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man. O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004 [TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous carbenicillin, cefoxitin and cefamandole on ADP-induced platelet aggregation and shape change. Fedder IL; Holme S; Vlasses PH; Ferguson RK; Murphy S Thromb Res; 1983 Oct; 32(2):215-22. PubMed ID: 6658713 [TBL] [Abstract][Full Text] [Related]
16. Anti-platelet and anti-thrombosis characteristics of Z4A5, a novel selective platelet glycoprotein IIb/IIIa inhibitor, compared with eptifibatide under long-term infusion. Shi XL; Shen S; Guo MM; Zhang GJ; Che J; Wang B; Zhou J Pharmazie; 2015 Dec; 70(12):810-4. PubMed ID: 26817279 [TBL] [Abstract][Full Text] [Related]
17. Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute. Okamura Y; Takeoka S; Eto K; Maekawa I; Fujie T; Maruyama H; Ikeda Y; Handa M J Thromb Haemost; 2009 Mar; 7(3):470-7. PubMed ID: 19143920 [TBL] [Abstract][Full Text] [Related]
18. Effect of hematocrit on adenosine diphosphate-induced aggregation of human platelets in tube flow. Goldsmith HL; Kaufer ES; McIntosh FA Biorheology; 1995; 32(5):537-52. PubMed ID: 8541523 [TBL] [Abstract][Full Text] [Related]
19. Vasoactive agents and production of thrombosis during intravascular coagulation 1--comparative effects of norepinephrine in thrombin and adenosine diphosphate (ADP) treated rabbits. Latour JG; Léger-Gauthier C; Daoust-Fiorilli J Pathology; 1984 Oct; 16(4):411-7. PubMed ID: 6522106 [TBL] [Abstract][Full Text] [Related]
20. In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit. Sandoli D; Chiu PJ; Chintala M; Dionisotti S; Ongini E Eur J Pharmacol; 1994 Jun; 259(1):43-9. PubMed ID: 7957592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]